Which data point is most valuable in judging long-term SNM efficacy?

• A. Sustained reduction in symptom frequency and severity over months to years.
• B. Immediate symptom relief within days.
• C. Only battery life extension.
• D. Number of visits to the clinic.

Answer: (A)

Durable improvement over time is the best way to judge long-term SNM efficacy. Sacral neuromodulation aims to produce lasting reductions in how often and how severely symptoms occur, so looking at sustained changes over months to years shows whether the therapy truly helps in the real world, beyond initial or short-lived effects. Immediate relief within days can happen but may not persist, so it doesn’t reliably indicate long-term benefit. Battery life extension is a hardware consideration, not a measure of symptom control, and the number of clinic visits reflects care or monitoring rather than direct efficacy. Tracking symptom frequency and severity over an extended period provides the most meaningful evidence of durable SNM success.